Pfizer Drops Remoxy: Durect And Pain Therapeutics Suffer

Pain Therapeutics and Durect announced on Monday morning that Pfizer will discontinue development of Remoxy (Extended-Release oxycodone) and will return all rights to Pain Therapeutics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.